- 201-500 Employees
- Based in Lexington, Massachusetts
Agenus Inc., a biotechnology company, develops and commercializes immunotherapies for cancer and infectious diseases. It markets Oncophage vaccine for the treatment of adjuvant renal cell carcinoma (kidney cancer).
REPORT RATINGS4.8 / 5.0 (176)
Agenus Inc. reports have an aggregate usefulness score of 4.8 based on 176 reviews.
Most Recent Annual Report
2022 Annual Report and Form 10K
Older/Archived Annual Reports